Related Experiment Videos
Sustained decrease in cocaine-maintained responding in rhesus monkeys with
J R Glowa1, W E Fantegrossi, D B Lewis
1Department of Psychiatry, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814, USA.
Journal of Medicinal Chemistry
|November 22, 1996
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Efficiency and cross-bridge work output of skeletal muscle is decreased at low levels of activation.
Pflugers Archiv : European journal of physiology·2013
Dental abnormalities in Schimke immuno-osseous dysplasia.
Journal of dental research·2012
Protein tyrosine kinase 7: a novel surface marker for human recent thymic emigrants with potential clinical utility.
Journal of perinatology : official journal of the California Perinatal Association·2011
Octamer proteins inhibit IL-4 gene transcription in normal human CD4 T cells.
Genes and immunity·2002
Group A streptococcal meningitis: report of a case and review of literature since 1976.
Pediatric emergency care·2001
A randomization test-based method for risk assessment in neurotoxicology.
Risk analysis : an official publication of the Society for Risk Analysis·2001
Discovery and Optimization of Novel Nonhydroxamate LpxC Inhibitors for the Treatment of Multidrug-Resistant Gram-Negative Infections.
Journal of medicinal chemistry·2026
Fragment-Based Discovery of Potent RNA-Competitive Inhibitors of the DEAH-Box RNA Helicase DHX8.
Journal of medicinal chemistry·2026
Discovery and Optimization of a WRN Helicase Inhibitor Series through Structure-Guided Drug Design from a Covalent Fragment Binding Insight.
Journal of medicinal chemistry·2026
Recent Advances in Antiviral Medicinal Chemistry against Flaviviruses Driven by Multistrategic Approaches.
Journal of medicinal chemistry·2026
Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.
Canadian journal of kidney health and disease·2026
Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.
Therapeutic advances in neurological disorders·2026